Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Recipharm Kaysersberg is a specialized contract manufacturing organization (CMO) facility located in France, operating as a subsidiary of the Recipharm Group. The plant is a global center of excellence for Blow-Fill-Seal (BFS) technology, providing automated aseptic filling for sterile liquids such as ophthalmic solutions and respiratory drugs. Originally a facility for Alcon, the site was acquired by Recipharm to bolster its sterile manufacturing capabilities. It offers end-to-end services from clinical trial material production to large-scale commercial manufacturing, adhering to strict GMP standards for global markets including the US and Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kayserberg Plant.